These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 24558198
1. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer. Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J, Zhang HT. FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198 [Abstract] [Full Text] [Related]
2. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang HT, Zhao J. Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033 [Abstract] [Full Text] [Related]
3. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P, Liu WL. Int J Clin Exp Pathol; 2015 Jul; 8(9):10800-7. PubMed ID: 26617792 [Abstract] [Full Text] [Related]
6. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer. Huo W, Zhu XM, Pan XY, Du M, Sun Z, Li ZM. Math Biosci Eng; 2019 May 23; 16(5):4607-4621. PubMed ID: 31499680 [Abstract] [Full Text] [Related]
8. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y. Eur J Cancer; 2014 Sep 23; 50(13):2336-50. PubMed ID: 25001183 [Abstract] [Full Text] [Related]
10. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer. Zhu X, Gao G, Chu K, Yang X, Ren S, Li Y, Wu H, Huang Y, Zhou C. Int J Biochem Cell Biol; 2015 Apr 23; 61():103-14. PubMed ID: 25687035 [Abstract] [Full Text] [Related]
11. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer. Shi X, Zhan L, Xiao C, Lei Z, Yang H, Wang L, Zhao J, Zhang HT. Oncotarget; 2015 Aug 07; 6(22):19043-54. PubMed ID: 26189214 [Abstract] [Full Text] [Related]
14. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway. Li WQ, Zhang JP, Wang YY, Li XZ, Sun L. Cell Cycle; 2019 Aug 07; 18(15):1727-1744. PubMed ID: 31204561 [Abstract] [Full Text] [Related]
15. MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. Wang X, Chen X, Meng Q, Jing H, Lu H, Yang Y, Cai L, Zhao Y. Sci Rep; 2015 Dec 01; 5():17618. PubMed ID: 26620926 [Abstract] [Full Text] [Related]
16. MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS. Fan Q, Hu X, Zhang H, Wang S, Zhang H, You C, Zhang CY, Liang H, Chen X, Ba Y. Cell Physiol Biochem; 2017 Dec 01; 44(4):1311-1324. PubMed ID: 29183007 [Abstract] [Full Text] [Related]
17. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis. Wang DT, Ma ZL, Li YL, Wang YQ, Zhao BT, Wei JL, Qi X, Zhao XT, Jin YX. Oncol Rep; 2013 Jul 01; 30(1):492-8. PubMed ID: 23670238 [Abstract] [Full Text] [Related]
18. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6. Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F, Li D. Biochem Biophys Res Commun; 2016 Feb 26; 471(1):82-8. PubMed ID: 26845350 [Abstract] [Full Text] [Related]
19. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7. Han L, Wang W, Ding W, Zhang L. J Cell Mol Med; 2017 Sep 26; 21(9):2000-2008. PubMed ID: 28266181 [Abstract] [Full Text] [Related]
20. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Gu H, Yang T, Fu S, Chen X, Guo L, Ni Y. Biochem Biophys Res Commun; 2014 Jan 31; 444(1):104-8. PubMed ID: 24440705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]